About Prostaglandin D2 receptor
Prostaglandin D2 receptor (PTGDR) is a protein
from Homo sapiens identified by UniProt accession
Q13258, 359 residues long.
MolForge cross-references it against 0 known binders and
288 disease associations.
Target properties
| Protein name | Prostaglandin D2 receptor |
| UniProt accession | Q13258 |
| Gene | PTGDR |
| Organism | Homo sapiens |
| Length | 359 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (10)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (288)
Diseases linked to this target (Open Targets).
- Hypercholesterolemia · score 0.53
- Disorder of lipid metabolism · score 0.48
- polycystic ovary syndrome · score 0.37
- coronary artery disease · score 0.37
- Combined hyperlipidemia · score 0.35
- hyperlipidemia · score 0.35
- type 2 diabetes mellitus · score 0.27
- familial hypercholesterolemia · score 0.26
- eosinophil count · score 0.25
- ovarian cancer · score 0.23
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13258-F1 | alphafold | PREDICTED | 79.39 | — |
Amino-acid sequence (359 residues)
MKSPFYRCQN TTSVEKGNSA VMGGVLFSTG LLGNLLALGL LARSGLGWCS RRPLRPLPSV FYMLVCGLTV TDLLGKCLLS PVVLAAYAQN RSLRVLAPAL DNSLCQAFAF FMSFFGLSST LQLLAMALEC WLSLGHPFFY RRHITLRLGA LVAPVVSAFS LAFCALPFMG FGKFVQYCPG TWCFIQMVHE EGSLSVLGYS VLYSSLMALL VLATVLCNLG AMRNLYAMHR RLQRHPRSCT RDCAEPRADG REASPQPLEE LDHLLLLALM TVLFTMCSLP VIYRAYYGAF KDVKEKNRTS EEAEDLRALR FLSVISIVDP WIFIIFRSPV FRIFFHKIFI RPLRYRSRCS NSTNMESSL
Explore Prostaglandin D2 receptor with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets